Cargando…

Management of large and surrounding tissue infiltrative anal fistula cancer: Two case reports

INTRODUCTION: Adenocarcinoma originating from chronic perianal fistulas is a rare disease. Due to the lack of evidence of this malignancy, no definitive diagnostic and treatment guidelines have been established. We present two cases of anal fistula cancer and discuss the diagnostic and treatment str...

Descripción completa

Detalles Bibliográficos
Autores principales: An, Sang Hyun, Kim, Ik Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7708865/
https://www.ncbi.nlm.nih.gov/pubmed/33395864
http://dx.doi.org/10.1016/j.ijscr.2020.11.107
_version_ 1783617629652516864
author An, Sang Hyun
Kim, Ik Yong
author_facet An, Sang Hyun
Kim, Ik Yong
author_sort An, Sang Hyun
collection PubMed
description INTRODUCTION: Adenocarcinoma originating from chronic perianal fistulas is a rare disease. Due to the lack of evidence of this malignancy, no definitive diagnostic and treatment guidelines have been established. We present two cases of anal fistula cancer and discuss the diagnostic and treatment strategies. PRESENTATION OF CASE: A 79-year-old man was referred for a perianal mass. The patient had a history of chronic perianal fistula and was diagnosed with adenocarcinoma originating from a long-standing perianal fistula. The patient underwent laparoscopic abdominoperineal resection (APR) without any adjuvant therapy. The second case was a 42-year old man, who was referred for a prolapsed anal mass. The patient had recurrent perianal fistula over several years. He was diagnosed with mucinous adenocarcinoma originating from a long-standing perianal fistula, but he initially refused surgical treatment. Two years later, the patient revisited with a huge overgrown tumor and underwent laparoscopic APR with wide perineal skin excision, wound debridement and coverage with a bilateral V-Y advancement flap via a one-step procedure. DISCUSSION: High degree of clinical suspicion is crucial to diagnose this rare disease that can easily be missed at an early stage. Depending on the disease stage, surgical treatment, chemotherapy, and radiotherapy can be considered. CONCLUSION: Histopathological evaluation should be performed on recurrent and incurable anal fistulas over a long period of time. Intensive surgical treatment with or without neoadjuvant and adjuvant therapy should be considered in advanced cases.
format Online
Article
Text
id pubmed-7708865
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-77088652020-12-09 Management of large and surrounding tissue infiltrative anal fistula cancer: Two case reports An, Sang Hyun Kim, Ik Yong Int J Surg Case Rep Case Report INTRODUCTION: Adenocarcinoma originating from chronic perianal fistulas is a rare disease. Due to the lack of evidence of this malignancy, no definitive diagnostic and treatment guidelines have been established. We present two cases of anal fistula cancer and discuss the diagnostic and treatment strategies. PRESENTATION OF CASE: A 79-year-old man was referred for a perianal mass. The patient had a history of chronic perianal fistula and was diagnosed with adenocarcinoma originating from a long-standing perianal fistula. The patient underwent laparoscopic abdominoperineal resection (APR) without any adjuvant therapy. The second case was a 42-year old man, who was referred for a prolapsed anal mass. The patient had recurrent perianal fistula over several years. He was diagnosed with mucinous adenocarcinoma originating from a long-standing perianal fistula, but he initially refused surgical treatment. Two years later, the patient revisited with a huge overgrown tumor and underwent laparoscopic APR with wide perineal skin excision, wound debridement and coverage with a bilateral V-Y advancement flap via a one-step procedure. DISCUSSION: High degree of clinical suspicion is crucial to diagnose this rare disease that can easily be missed at an early stage. Depending on the disease stage, surgical treatment, chemotherapy, and radiotherapy can be considered. CONCLUSION: Histopathological evaluation should be performed on recurrent and incurable anal fistulas over a long period of time. Intensive surgical treatment with or without neoadjuvant and adjuvant therapy should be considered in advanced cases. Elsevier 2020-11-21 /pmc/articles/PMC7708865/ /pubmed/33395864 http://dx.doi.org/10.1016/j.ijscr.2020.11.107 Text en © 2020 The Author(s) http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Case Report
An, Sang Hyun
Kim, Ik Yong
Management of large and surrounding tissue infiltrative anal fistula cancer: Two case reports
title Management of large and surrounding tissue infiltrative anal fistula cancer: Two case reports
title_full Management of large and surrounding tissue infiltrative anal fistula cancer: Two case reports
title_fullStr Management of large and surrounding tissue infiltrative anal fistula cancer: Two case reports
title_full_unstemmed Management of large and surrounding tissue infiltrative anal fistula cancer: Two case reports
title_short Management of large and surrounding tissue infiltrative anal fistula cancer: Two case reports
title_sort management of large and surrounding tissue infiltrative anal fistula cancer: two case reports
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7708865/
https://www.ncbi.nlm.nih.gov/pubmed/33395864
http://dx.doi.org/10.1016/j.ijscr.2020.11.107
work_keys_str_mv AT ansanghyun managementoflargeandsurroundingtissueinfiltrativeanalfistulacancertwocasereports
AT kimikyong managementoflargeandsurroundingtissueinfiltrativeanalfistulacancertwocasereports